Important notes:
You MUST use this template. If you don’t use it your abstract may be rejected.
Do NOT enter author and institution information on this form. You will be able to enter this information online when you submit the abstract.
Do NOT write outside the boxes. Any text or images outside the boxes will be deleted. Do NOT alter this form by deleting parts of it or adding new boxes. Simply enter your information into the boxes. The form will be automatically processed – if you alter it your submission will not be processed correctly.
Save this file in .doc format. Other formats such as .docx (Word 2007) will be rejected.
Title: (your title MUST use upper and lower case letters (only use upper case to begin the first word and for proper nouns) and be in Bold Arial Size 10 font. Do not include a period after your title).
HGF/Met tyrosine kinase receptor in heart physiology and pathophysiology
Abstract: (Your abstract MUST use Arial Size 10 font (use Bold ONLY for section titles (e.g. Background, Methods, etc)) and must fit into the box (box can be stretched vertically; max 300 words) . Do not enter author details in this box.)
Our work has mainly investigated the role of HGF/Met tyrosine kinase receptor signaling in the heart during physiological and pathological conditions. Targeting HGF/Met activation in neonatal heart in vivo modulates the gene expression program involved in cardiomyogenesis. Furthermore, sustained activation of Met pathways in postnatal cardiomyocytes in vivo strongly increases the heart growth. Our research has also extended to the influence of Met activation in the heart protection against injury. Importantly, we have shown that Met stimulation by HGF protects cardiac cells from hypoxic damage both in vivo, in a mouse model of myocardial infarction, and in vitro, in cardiomyoblast cells cultured in low oxygen tension. Recently, we have shown that HGF protects cardiac cells from antracycline-mediated cardiotoxicity, showing that the induction of ROS-triggered apoptosis and autophagy is attenuated by HGF. In addition, our approach get closer to the clinic, with the development of original tools for therapeutic application.
